26 June 2024
Leading UK based biopharmaceutical company GSK has transformed its digital patientcare experience by working with adesso.
GSK needed a system in place to support patients during their treatment cycle. With thousands of patients around the globe in need of regular updates, it was critical to offer a solution that was easy to execute and provided high quality digital insights.
Working with adesso, the team developed the DREAM project, providing patients with personalised communications and reminders to improve their adherence to vaccines and medication. The new project has already been successfully rolled out to five key markets, with a further 10-15 on the way.
“One of our key reasons for existence as GSK is ‘Being Impactful for Patients.’ DREAM project is our revolutionary idea on helping patients improve their adherence to medicine and vaccines. We chose Adesso because of their expertise, agile approach to project management, and flexibility. This was needed as we were constantly learning and adapting to changing priorities. Their team was always willing to go the extra mile to find the best fitting solutions to even the most complex challenges, it’s harder to make things easier, and with this partnership, we achieved that,” said Necati Sebe, head of commercial operations and strategy at GSK.
“GSK is a fantastic brand which needed a digital solution that could completely transform its patientcare services. Having a customer-centric approach means prioritising user experience and ease of use at every stage of development within the process. Our agile methodology during development allowed for continuous communication and rapid problem-solving,” said Libero Raspa, managing director of adesso UK.
